(Q34425084)

2 August 2017

title

Cefditoren in vitro activity and spectrum: a review of international studies using reference methods (English)

1 reference

2 August 2017

1 reference

ChEBI release 2020-05-28

1

Jones RN

1 reference

2 August 2017

5

Fuchs PC

1 reference

2 August 2017

2

Pfaller MA

1 reference

2 August 2017

Jacobs MR

3

1 reference

2 August 2017

Appelbaum PC

series ordinal

4

1 reference

2 August 2017

language of work or name

1 reference

1 September 2001

1 reference

Diagnostic Microbiology and Infectious Disease

2 August 2017

published in

1 reference

2 August 2017

volume

41

1 reference

2 August 2017

issue

1-2

1 reference

2 August 2017

page(s)

1-14

1 reference

In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Novelties in the field of anti-infectives in 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

In vitro activity of a new cephalosporin ME-1206 compared with other agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

In vitro antibacterial activity of ME1207, a new oral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Synthesis and oral activity of ME1207, a new orally active cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Inoculum effect and bactericidal activity of cefditoren and other antibiotics against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900274-7

7 January 2021

10.1016/S0732-8893(01)00274-7

Identifiers

DOI

1 reference

2 August 2017

1 reference